Assenagon Asset Management S.A. Invests $1.45 Million in HealthEquity, Inc. (NASDAQ:HQY)

Assenagon Asset Management S.A. acquired a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 15,128 shares of the company's stock, valued at approximately $1,452,000.

Other large investors also recently modified their holdings of the company. Holocene Advisors LP acquired a new position in HealthEquity in the third quarter valued at approximately $1,246,000. GSA Capital Partners LLP bought a new stake in shares of HealthEquity in the 3rd quarter valued at $638,000. Natixis Advisors LLC lifted its position in shares of HealthEquity by 29.8% during the 3rd quarter. Natixis Advisors LLC now owns 209,175 shares of the company's stock valued at $17,122,000 after acquiring an additional 48,009 shares during the period. Vaughan Nelson Investment Management L.P. boosted its stake in HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company's stock worth $69,034,000 after acquiring an additional 226,563 shares in the last quarter. Finally, Loomis Sayles & Co. L P grew its holdings in HealthEquity by 2.2% in the third quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company's stock worth $92,216,000 after purchasing an additional 24,665 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the company's stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Frank Corvino sold 1,039 shares of HealthEquity stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the sale, the director now directly owns 3,784 shares in the company, valued at $363,642.40. The trade was a 21.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,289 shares of company stock valued at $3,355,718 over the last ninety days. 2.20% of the stock is owned by insiders.

HealthEquity Trading Up 2.1 %

NASDAQ:HQY traded up $2.17 during trading hours on Friday, reaching $106.88. The company's stock had a trading volume of 654,597 shares, compared to its average volume of 762,906. The firm has a 50-day simple moving average of $99.60 and a 200-day simple moving average of $87.35. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $107.87. The firm has a market capitalization of $9.26 billion, a price-to-earnings ratio of 98.06, a PEG ratio of 1.86 and a beta of 0.54.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the prior year, the business earned $0.40 EPS. Research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Bank of America upped their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a report on Wednesday, November 13th. Barrington Research raised their price target on shares of HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research report on Monday, December 2nd. The Goldman Sachs Group assumed coverage on HealthEquity in a report on Friday, November 15th. They set a "neutral" rating and a $108.00 price objective for the company. JMP Securities increased their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research note on Tuesday, December 10th. Finally, Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 target price on the stock. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, HealthEquity currently has a consensus rating of "Moderate Buy" and an average target price of $110.71.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.